Patient Relations
When screening shows elevated PSA levels or something unusual on exam, getting an accurate diagnosis is the next step. Our diagnostic services use advanced imaging and expert analysis to give you clear answers about what's going on.
Multiparametric MRI has changed how we find and diagnose prostate cancer. This scan shows us suspicious areas before we do a biopsy, helps us understand where the cancer is and how far it's spread, and lets us monitor men on active surveillance without needing repeated biopsies.
MRI helps us find cancers that actually matter while avoiding biopsies you don't need. It shows us exactly where to look and gives us better information upfront. Radiologists who specialize in prostate imaging read every scan.
If you need a biopsy, we use MRI/ultrasound fusion technology. This combines the detailed view from MRI with real-time ultrasound, so we can target the exact spots that look concerning while also checking the rest of the prostate.
Fusion biopsy finds more significant cancers and fewer insignificant ones than older methods. It's especially good at catching tumors in spots that standard biopsy often misses. If you're thinking about active surveillance, this accuracy matters. We make sure you're as comfortable as possible during the procedure.
Our pathologists analyze every tissue sample carefully. They use the Gleason grading system and Grade Groups to figure out how aggressive your cancer is. Gleason 6 (Grade Group 1) is the lowest grade and grows the slowest. Gleason 7 falls in the middle, with Grade Group 2 (3+4) and Grade Group 3 (4+3) having different levels of concern. Gleason 8 through 10 (Grade Groups 4 and 5) are the most aggressive.
We combine these grades with your PSA level and imaging to figure out the best path forward for you.
Sometimes we recommend genomic testing for extra information. If you have low-risk cancer and you're thinking about active surveillance, tests like Oncotype DX Prostate can predict how aggressive it's likely to be. After surgery, Decipher testing looks at your risk of the cancer spreading and helps us decide if you need additional treatment. For advanced disease, broader testing through Foundation One can find specific mutations that might respond to targeted therapies.
Depending on your situation, we might recommend more scans to see the full picture. This could include bone scans, CT scans of your abdomen and pelvis, a detailed pelvic MRI, or advanced PSMA PET scans if you have high-risk or returning cancer. We want complete information before we talk about treatment.
Getting a diagnosis is just one step. Based on what we find, our team will walk you through what happens next.
If we find cancer, our treatment team will create a plan tailored to your specific situation using the latest approaches in surgery, radiation, and other therapies.
If you have low-risk disease, our Active Surveillance Program lets you avoid treatment you might not need while keeping a close eye on things.
No matter what, our support services are here to help with the practical and emotional parts of dealing with a prostate cancer diagnosis.
Diagnosis is just one step in your comprehensive care at JHAH. Based on your results, our team will guide you seamlessly to the next phase of your journey.
If cancer is detected, our Treatment Options provide personalized therapy plans using the latest advances in surgery, radiation, hormone therapy, and systemic treatments.
For those at increased risk, our Prevention & Screening programs offer individualized screening strategies and enhanced surveillance based on your risk profile.
Our Specialized Programs bring together experts in prostate cancer to deliver personalized care for hereditary, advanced, and castration-resistant cases, with treatment plans tailored for your situation.
Throughout your journey, our Support & Survivorship Services ensure you have the emotional, practical, and educational resources you need.
